ÅǸ޴º
Á¦¸ñ | Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem) (ASCO Annual Meeting, Virtual, 2020) | µî·ÏÀÏ | 20200923 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem) (ASCO Annual Meeting, Virtual, 2020)
|
Copyright ¨Ï chamc, All rights reserved.